甲基胺的时间表:防止滥用或阻碍ADHD治疗的坚持?
Renata Schoeman1, Sophia Weinberg1
1Stellenbosch Business School, Bellville, South Africa.
在南非治疗注意力缺陷多动症 (ADHD) 的甲基化物 (MPH) 的重新安排可以改善治疗的坚持和可访问性. 然而,目前的法规作为护理的障碍,并不能有效防止滥用.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
背景情况:
- 注意缺陷多动性障碍 (ADHD) 是一种流行的神经发育障碍,如果不治疗,会导致慢性影响.
- 药物不合规严重影响ADHD患者的情绪,社会,教育和就业结果.
- 目前南非对甲基酸 (MPH) 的第6项分类制造了医疗保健障碍,增加了医疗费用.
研究的目的:
- 探索利益相关者对重新安排MPH对ADHD治疗可访问性和遵守性的影响的看法.
- 了解与MPH调度监管转变相关的潜在好处和风险.
主要方法:
- 对与23名参与南非ADHD管理的利益相关者进行的半结构面试的定性分析.
- 参与者通过专业网络招募.
主要成果:
- 六个主要主题出现了:遵守,可访问性,可负担性,耻辱感,MPH的重新安排和风险减轻.
- 计划MPH的双重作用,提供社会保护,但也阻碍获得护理.
- 利益相关者对MPH重新安排表达了积极的看法,表明可能会出现显著的积极变化.
结论:
- 目前MPH的第6项状态在防止滥用和转移方面无效,同时对治疗的坚持产生负面影响.
- 重新安排MPH对南非的ADHD景观产生了重大影响.
- 解决耻辱和消除结构性障碍对于改善ADHD结果至关重要,并得到新的治疗坚持框架的支持.
更多相关视频
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
相关概念视频
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Drug Therapy
Antianxiety Medications
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
